Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients
NCT ID: NCT03070912
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
257 participants
OBSERVATIONAL
2018-01-19
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding
NCT04466878
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
NCT05773638
Impact of Von Willebrand Factor and Its Multimers on Angiogenesis
NCT04810702
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NCT04119908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient supplied by an ECMO for cardiac or respiratory failure and referred to Lille University Hospital
* patient affiliated to "french social security"
Exclusion Criteria
* no consent
* no affiliation to
* patient affiliated to '
* preexisting bleeding disorders
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine RAUCH, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH ARRAS
Arras, , France
CH Boulogne
Boulogne-sur-Mer, , France
CH DOUAI
Douai, , France
CH Dunkerque
Dunkirk, , France
Hôpital Cardiologie, CHU
Lille, , France
Ch Tourcoing
Tourcoing, , France
Ch Valenciennes
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moussa MD, Abou-Arab O, Staessens S, Jungling M, Labreuche J, Lamer A, Beyls C, Rousse N, Rauch A, Loobuyck V, Beaudeux C, Pierache A, Deblauwe D, Corseaux D, Dubernet M, Guilbart M, Thellier L, Mahjoub Y, Juthier F, Dupont H, De Meyer SF, Vincentelli A, Susen S, Robin E. Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: a propensity score weighted analysis. J Thromb Haemost. 2025 Jun;23(6):1879-1892. doi: 10.1016/j.jtha.2025.02.020. Epub 2025 Feb 26.
Rauch A, Dupont A, Rosa M, Desvages M, Le Tanno C, Abdoul J, Didelot M, Ung A, Ruez R, Jeanpierre E, Daniel M, Corseaux D, Spillemaeker H, Labreuche J, Pradines B, Rousse N, Lenting PJ, Moussa MD, Vincentelli A, Bordet JC, Staels B, Vincent F, Denis CV, Van Belle E, Casari C, Susen S. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia. Circ Res. 2023 Oct 27;133(10):826-841. doi: 10.1161/CIRCRESAHA.123.322752. Epub 2023 Oct 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00256-47
Identifier Type: OTHER
Identifier Source: secondary_id
2015_83
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.